Our results indicated that inhibition of c-Myc increased drug's cytotoxicity after demethylating treatment, it was consistent with previous studies in chronic myeloid leukemia [34]. Here, MYC is linked to chronic myelogenous leukemia, BCR-ABL1 positive.